COVID-19

MGC Pharma's COVID-19 Treatment Shows No Pathological Impact on Major Organs

MGC Pharmaceuticals' latest animal study on its novel COVID-19 treatment 'ArtemiC', revealed the formula causes "no pathological changes" in major organs.MGC Pharmaceuticals (ASX: ...

Study Finds Cannabis May Help With COVID-19

Researchers from the University of South Carolina performed studies on mice with COVID-19, that suggest THC may help to mitigate the harmful impacts of the virus. As the world cont...

MGC Pharma Provides Update on COVID-19 Treatment

MGC Pharmaceuticals (ASX:MXC) has provided an update on the clinical trials involving the company's novel formula 'ArtemiC' to treat COVID-19 patients. MGC Pharmaceuticals Ltd (ASX...

Latest COVID-19 Aid Bill Includes SAFE Cannabis Banking Act

Could the cannabis industry finally gain access to financial institutions? The latest COVID-19 stimulus bill seeks to ensure it does. House Democrats have proposed a new $2.2 trill...

FreshLeaf Analytics Q3 Cannabis Report Reveals Biggest Price Drop Since 2016

Cannabis industry revenue is also expected to triple during 2020—growing to approximately $95 million—while active patient numbers are on schedule to reach 30,000 before the ye...

Incannex Testing the Potential of a Hydroxychloroquine-Cannabidiol Formulation

Incannex recently announced positive results for their hydroxychloroquine-cannabidiol formulation, which can potentially treat the inflammatory conditions associated with COVID-19....

These Two ASX-Listed Cannabis Biotechs are Working on a COVID-19 Treatment

As the COVID-19 pandemic stretches on, many companies are vying to come up with a treatment - including two ASX-listed cannabis companies. Throughout the world, over 25 million cas...

More People Are Consuming Cannabis During COVID-19

Cannabis sales are going up, medicinal marijuana prescriptions are increasing, and self-reported cannabis consumption rates are spiking - all during the COVID-19 pandemic. As we di...

MGC Pharma Begins Registration Process for ArtemiC in Russia

MGC Pharmaceuticals plans to establish a joint venture company to register ArtemiC in Russia. MGC Pharmaceuticals Ltd (ASX: MXC), the Europe-based cannabis biotech today announced ...

Animal Study Confirms Safety of MGC Pharma's 'ArtemiC'

MGC Pharmaceuticals undertook safety and toxicity pre-clinical studies using in vivo testing on mice in Israel and found that ArtemiC delivered "no adverse results in standard toxi...